US20070104756A1 - Obesity controlling method - Google Patents

Obesity controlling method Download PDF

Info

Publication number
US20070104756A1
US20070104756A1 US11/478,560 US47856006A US2007104756A1 US 20070104756 A1 US20070104756 A1 US 20070104756A1 US 47856006 A US47856006 A US 47856006A US 2007104756 A1 US2007104756 A1 US 2007104756A1
Authority
US
United States
Prior art keywords
wall
implant
stomach
forming material
gastrointestinal tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/478,560
Inventor
Larry Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temple University of Commonwealth System of Higher Education
Original Assignee
Temple University of Commonwealth System of Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temple University of Commonwealth System of Higher Education filed Critical Temple University of Commonwealth System of Higher Education
Priority to US11/478,560 priority Critical patent/US20070104756A1/en
Publication of US20070104756A1 publication Critical patent/US20070104756A1/en
Priority to US12/566,886 priority patent/US20100204673A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/0076Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
    • A61F5/0079Pyloric or esophageal obstructions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Definitions

  • the present invention relates to a method of controlling obesity by injecting bio-compatible bulking material into the pyloric sphincter area of the stomach.
  • the injection of this material bulks the pyloric sphincter, retarding stomach emptying and producing a feeling of satiation in the patient.
  • Obesity is one of the major causes of heart disease, lipid abnormalities, hypertension and osteoarthritis. Treatment of obesity has the potential to lower the risk of all of these diseases as well as improve the condition of patients who already suffer from such illnesses. In addition, it is well known that a large percentage of Americans and Europeans are considered to be obese based on height and weight ratios issued by the World Health Organization (WHO). These numbers in conjunction with the dangerous diseases affiliated with or caused by obesity indicate that there is a substantial need for effective treatment.
  • WHO World Health Organization
  • the present invention provides a minimally invasive method for controlling obesity comprising injecting a bio-compatible bulking material submucosally or intramuscularly into the pyloric area of the stomach in an amount sufficient to cause the lumen of pylorus to narrow and slow gastric emptying.
  • the invention is a method of treating obesity in which gastric emptying is slowed by narrowing the pyloric sphincter or pylorus.
  • the invention comprises injecting a bio-compatible bulking material into the pyloric area of the stomach, preferably either submucosally or intramuscularly.
  • the pylorus can be caused to narrow by the injection of a bio-compatible bulking material into the mucosal or muscular area around the pylorus.
  • a bio-compatible bulking material into the mucosal or muscular area around the pylorus.
  • Such an injection can be accomplished by a two step process wherein an endoscopy is performed to locate the pylorus and a needle is placed through the biopsy channel of the endoscope in order to inject the bulking material.
  • Such an injection will increase the bulk of the pylorus and thus narrow the gastric outlet from the stomach to the start of the small intestines.
  • the bio-compatible bulking materials suitable for the present invention include collagen, fibrin and elastin as well as other naturally occurring and synthetically derived bio-compatible polymers. Certain polymers such as collagen or fibrin glue have been demonstrated to be well tolerated when injected into lumen in humans. In addition, such materials are commercially available. For instance, collagen may be purchased from FribroGen, Inc., Cohesion Technologies, Inc., Hydromer, Inc., and Bard, Inc., and fibrin glue may be purchased from Abbott Laboratories, Inc.
  • Contigen is a registered trademark of the Collagen Corporation and is a protein composition for medical implants for relief of urinary tract disorders
  • Zyderm is a registered trademark of the Collagen Corporation and is a protein composition for dermal implantation
  • Zyplast is a registered trademark of the Collagen Corporation and is a collagen implant used for soft tissue augmentation
  • rh collagen is a registered trademark of the Collagen Corporation and is a collagen implant used for soft tissue augmentation
  • Dermalogen.®TM Dermalogen
  • Dermalogen is a registered trademark of Collagenesis, Inc. and is injectable human tissue for treating wrinkles and scars
  • Autologen.®TM Autologen is a registered trademark of Autogenesis Technologies, Inc. and is processed collagen for implantation
  • autologous fat is a registered trademark of Autogenesis Technologies, Inc.
  • Collagen for use in the present invention can be from several sources including porcine, bovine, or human. It can be either fibrillar or nonfibrillar. Collagen can be administered in aqueous solution form or in the denatured state as gelatin. In addition, it can be administered in either a crosslinked or a non-crosslinked form.
  • collagen is preferred as the bio-compatible bulking material to be injected into the pyloric muscle
  • other materials can be used.
  • the amount of bio-compatible bulking material injected into the pyloric area of the stomach will be dependent of a variety of factors. For instance, the size of the individual, the severity of the individual's obesity, and the shape and distension of the pylorus will all be determinative in calculating the amount of bulking material injected. It is estimated that the opening of the pyloric sphincter can be reduced at least 10% and up to 90% by the instant invention.
  • the injection of collagen or fibrin glue into the pylorus is expected to last for 3 to 12 months. If the body absorbs the bio-compatible bulking material, it can be re-injected by a repeat of the method described. If the narrowing of the pylorus is found to be too great, the opening can be increased by the use of a balloon, which can be inserted into the pylorus and inflated to increase the opening. This flexibility in adjusting the pyloric opening to accommodate specific patent requirements provides a unique advantage over present surgical procedures.
  • the invention may encompass additional support procedures.
  • the pyloric area can also be narrowed by intentionally scarring the pyloric area with either a laser or a thermal device.
  • a laser or heating device could be placed through the biopsy channel of the endoscope and used to cauterize an area of the pylorus.
  • a sewing device could be placed through the biopsy channel of the endoscope and used to sew the pylorus and narrow the opening of the pyloric sphincter.
  • gastric emptying can be further delayed by inducing a flaccid paralysis of the of the stomach.
  • Botulinum toxin will cause a paralysis of the stomach if it is strategically injected into either the muscles of the fundus or the antrum of the stomach. Paralyzing the stomach in this way will prolong satiety by further delaying gastric emptying.
  • the effects of botulinum toxin is expected to last for a period of 9 to 18 months.

Abstract

A method of controlling obesity by injecting bio-compatible bulking material into the pyloric sphincter area of the stomach. The injection of this material bulks the pyloric sphincter, retarding stomach emptying and producing a feeling of satiation in the patient. The method may be supplemental and augmented by inducing flacid paralysis of the stomach by injecting botulinum toxin into the muscle tissue of the antrum or fundus of the stomach.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. patent application Ser. No. 10/343,668 filed Aug. 13, 2003, which is a National Phase Application of International Patent Application No. PCT/US01/24971 filed Aug. 9, 2001, which claims priority of U.S. Provisional Application No. 60/224,324 filed Aug. 11, 2000.
  • The present invention relates to a method of controlling obesity by injecting bio-compatible bulking material into the pyloric sphincter area of the stomach. The injection of this material bulks the pyloric sphincter, retarding stomach emptying and producing a feeling of satiation in the patient.
  • BACKGROUND OF THE INVENTION
  • Obesity is one of the major causes of heart disease, lipid abnormalities, hypertension and osteoarthritis. Treatment of obesity has the potential to lower the risk of all of these diseases as well as improve the condition of patients who already suffer from such illnesses. In addition, it is well known that a large percentage of Americans and Europeans are considered to be obese based on height and weight ratios issued by the World Health Organization (WHO). These numbers in conjunction with the dangerous diseases affiliated with or caused by obesity indicate that there is a substantial need for effective treatment.
  • Current weight reduction programs usually include administration of systemic medications, which suppress the appetite or reduce the fat and/or sugar uptake of the digest track. However, systemic medications often display side effects some of which may be severe. Dietary changes that reduce caloric intake are also prescribed for the treatment of obesity, but such treatment requires rigorous compliance by the patient for effectiveness and is often ineffective as a result of non-compliance. In addition, surgery, which bypasses a portion of the stomach and/or the small intestine, is also used in the treatment of obesity. Surgical methods, however, are highly invasive and subject a patient to all the possible risks involved with major surgery including infection.
  • Safe and effective treatment is a long felt need in the treatment of obesity. Because of complications and/or ineffectiveness associated with current treatments a minimally invasive, effective treatment is preferred and is provided by the method of this invention.
  • BRIEF SUMMARY OF THE INVENTION
  • The present invention provides a minimally invasive method for controlling obesity comprising injecting a bio-compatible bulking material submucosally or intramuscularly into the pyloric area of the stomach in an amount sufficient to cause the lumen of pylorus to narrow and slow gastric emptying.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The entire disclosure of U.S. patent application Ser. Nos. 10/343,668 filed Aug. 13, 2003 and U.S. Provisional Application No. 60/224,324 filed Aug. 11, 2000 are expressly incorporated by reference herein.
  • The invention is a method of treating obesity in which gastric emptying is slowed by narrowing the pyloric sphincter or pylorus. The invention comprises injecting a bio-compatible bulking material into the pyloric area of the stomach, preferably either submucosally or intramuscularly. By narrowing the pyloric region of the stomach, the stomach will fill more quickly and empty more slowly as a patient eats. The clinical effect of this treatment will be to increase the time the patient feels satiated after eating, therefore decreasing the need and desire to eat and reducing the caloric intake of the patient.
  • The pylorus can be caused to narrow by the injection of a bio-compatible bulking material into the mucosal or muscular area around the pylorus. Such an injection can be accomplished by a two step process wherein an endoscopy is performed to locate the pylorus and a needle is placed through the biopsy channel of the endoscope in order to inject the bulking material. Such an injection will increase the bulk of the pylorus and thus narrow the gastric outlet from the stomach to the start of the small intestines.
  • The bio-compatible bulking materials suitable for the present invention include collagen, fibrin and elastin as well as other naturally occurring and synthetically derived bio-compatible polymers. Certain polymers such as collagen or fibrin glue have been demonstrated to be well tolerated when injected into lumen in humans. In addition, such materials are commercially available. For instance, collagen may be purchased from FribroGen, Inc., Cohesion Technologies, Inc., Hydromer, Inc., and Bard, Inc., and fibrin glue may be purchased from Abbott Laboratories, Inc. Various other similar products for injection include, but are not limited to, Contigen.®™ (Contigen is a registered trademark of the Collagen Corporation and is a protein composition for medical implants for relief of urinary tract disorders), Zyderm.®™ (Zyderm is a registered trademark of the Collagen Corporation and is a protein composition for dermal implantation), Zyplast.®™ (Zyplast is a registered trademark of the Collagen Corporation and is a collagen implant used for soft tissue augmentation), rh collagen, Dermalogen.®™ (Dermalogen is a registered trademark of Collagenesis, Inc. and is injectable human tissue for treating wrinkles and scars), Autologen.®™ (Autologen is a registered trademark of Autogenesis Technologies, Inc. and is processed collagen for implantation), and autologous fat.
  • Collagen for use in the present invention can be from several sources including porcine, bovine, or human. It can be either fibrillar or nonfibrillar. Collagen can be administered in aqueous solution form or in the denatured state as gelatin. In addition, it can be administered in either a crosslinked or a non-crosslinked form.
  • Although collagen is preferred as the bio-compatible bulking material to be injected into the pyloric muscle, other materials can be used. For instance, Teflon paste, synthetic polymeric hydrogels, glycoaminoglycans, proteoglycans, silicone microimplants, Durasphere.®™ (Durasphere is a registered trademark of Advanced UroScience, Inc. and consists of biocompatible, implantable microspheres for local tissue augmentation), and microbeads suspended in biological fluid lubricants such as dextran have been demonstrated to be tolerated when injected into human lumen.
  • The amount of bio-compatible bulking material injected into the pyloric area of the stomach will be dependent of a variety of factors. For instance, the size of the individual, the severity of the individual's obesity, and the shape and distension of the pylorus will all be determinative in calculating the amount of bulking material injected. It is estimated that the opening of the pyloric sphincter can be reduced at least 10% and up to 90% by the instant invention.
  • The injection of collagen or fibrin glue into the pylorus is expected to last for 3 to 12 months. If the body absorbs the bio-compatible bulking material, it can be re-injected by a repeat of the method described. If the narrowing of the pylorus is found to be too great, the opening can be increased by the use of a balloon, which can be inserted into the pylorus and inflated to increase the opening. This flexibility in adjusting the pyloric opening to accommodate specific patent requirements provides a unique advantage over present surgical procedures.
  • While the injection of the bulking bio-compatible bulking material into the pyloric area will control obesity, the invention may encompass additional support procedures. For instance, the pyloric area can also be narrowed by intentionally scarring the pyloric area with either a laser or a thermal device. In such an embodiment of the invention, a laser or heating device could be placed through the biopsy channel of the endoscope and used to cauterize an area of the pylorus. In addition, in another embodiment of the invention, a sewing device could be placed through the biopsy channel of the endoscope and used to sew the pylorus and narrow the opening of the pyloric sphincter.
  • In yet another embodiment of the invention, gastric emptying can be further delayed by inducing a flaccid paralysis of the of the stomach. Botulinum toxin will cause a paralysis of the stomach if it is strategically injected into either the muscles of the fundus or the antrum of the stomach. Paralyzing the stomach in this way will prolong satiety by further delaying gastric emptying. The effects of botulinum toxin is expected to last for a period of 9 to 18 months.

Claims (20)

1. A method for treating obesity in a body of a patient having a mouth and a gastrointestinal tract extending through a stomach and a pyloric sphincter formed by a wall comprising passing an implant-forming material through the mouth and down the gastrointestinal tract to the vicinity of the pyloric sphincter and forming at least one implant in the wall in the vicinity of the pyloric sphincter from the implant-forming material to retard emptying of the stomach.
2. The method of claim 1 wherein the wall has a muscle layer, the at least one implant being formed in the muscle layer of the wall.
3. The method of claim 1 wherein the passing step includes the step of introducing an endoscope through the mouth and into the gastrointestinal tract and passing the implant-forming material through the endoscope.
4. The method of claim 3 wherein the forming step includes the step of injecting the implant-forming material into the wall.
5. A method for treating obesity in a body of a patient having a mouth and a gastrointestinal tract extending through a stomach formed by a wall comprising passing an implant-forming material through the mouth and down the gastrointestinal tract to the stomach and forming at least one implant in the wall of the stomach from the implant-forming material to provoke longer periods of satiety.
6. The method of claim 5 wherein the wall has a muscle layer, the at least one implant being formed in the muscle layer of the wall.
7. The method of claim 5 wherein the passing step includes the step of introducing an endoscope through the mouth and into the gastrointestinal tract and passing the implant-forming material through the endoscope.
8. The method of claim 7 wherein the forming step includes the step of injecting the implant-forming material into the wall.
9. A method for treating obesity in a body of a patient having a gastrointestinal tract extending through a stomach and a pyloric sphincter formed by a wall comprising the step of forming at least one implant in the wall in the vicinity of the pyloric sphincter to retard emptying of the stomach.
10. The method of claim 9 wherein the wall has a muscle layer, the at least one implant being formed in the muscle layer of the wall.
11. A method for treating obesity in a body of a patient having a gastrointestinal tract extending through a stomach formed by a wall, comprising the step of introducing a solution into the wall of the stomach to form at least one implant in the wall so as to provoke longer periods of satiety.
12. The method of claim 11 wherein the wall has a muscle layer, the at least one implant being formed in the muscle layer of the wall.
13. A method for treating morbid obesity in a body of a mammal having a mouth and a gastrointestinal tract extending through a stomach and a pyloric sphincter formed by a wall comprising passing an implant-forming material through the mouth and down the gastrointestinal tract to the vicinity of the pyloric sphincter and forming at least one implant in the wall in the vicinity of the pyloric sphincter from the implant-forming material to inhibit emptying of the stomach.
14. The method of claim 13 wherein the wall has a muscle layer, the at least one implant being formed in the muscle layer of the wall.
15. The method of claim 13 wherein the passing step includes the step of introducing a catheter through the mouth and into the gastrointestinal tract and passing the implant-forming material through the catheter.
16. The method of claim 15 wherein the forming step includes the step of injecting the implant-forming material into the wall.
17. A method for treating morbid obesity in a body of a mammal having a mouth and a gastrointestinal tract extending through a stomach formed by a wall comprising passing an implant-forming material through the mouth and down the gastrointestinal tract to the stomach and forming at least one implant in the wall of the stomach from the implant-forming material to is provoke longer periods of satiety.
18. The method of claim 17 wherein the wall has a muscle layer, the at least one implant being formed in the muscle layer of the wall.
19. The method of claim 17 wherein the passing step includes the step of introducing a catheter through the mouth and into the gastrointestinal tract and passing the implant-forming material through the catheter.
20. The method of claim 19 wherein the forming step includes the step of injecting the implant-forming material into the wall.
US11/478,560 2000-08-11 2006-06-29 Obesity controlling method Abandoned US20070104756A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US11/478,560 US20070104756A1 (en) 2000-08-11 2006-06-29 Obesity controlling method
US12/566,886 US20100204673A1 (en) 2000-08-11 2009-09-25 Obesity controlling method

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22432400P 2000-08-11 2000-08-11
PCT/US2001/024971 WO2002013854A1 (en) 2000-08-11 2001-08-09 Obesity controlling method
US10/343,668 US7608578B2 (en) 2000-08-11 2001-08-09 Obesity controlling method
US11/478,560 US20070104756A1 (en) 2000-08-11 2006-06-29 Obesity controlling method

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US10/343,668 Continuation US7608578B2 (en) 2000-08-11 2001-08-09 Obesity controlling method
PCT/US2001/024971 Continuation WO2002013854A1 (en) 2000-08-11 2001-08-09 Obesity controlling method

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/566,886 Continuation US20100204673A1 (en) 2000-08-11 2009-09-25 Obesity controlling method

Publications (1)

Publication Number Publication Date
US20070104756A1 true US20070104756A1 (en) 2007-05-10

Family

ID=22840162

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/343,668 Expired - Fee Related US7608578B2 (en) 2000-08-11 2001-08-09 Obesity controlling method
US11/478,560 Abandoned US20070104756A1 (en) 2000-08-11 2006-06-29 Obesity controlling method
US12/566,886 Abandoned US20100204673A1 (en) 2000-08-11 2009-09-25 Obesity controlling method

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/343,668 Expired - Fee Related US7608578B2 (en) 2000-08-11 2001-08-09 Obesity controlling method

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/566,886 Abandoned US20100204673A1 (en) 2000-08-11 2009-09-25 Obesity controlling method

Country Status (7)

Country Link
US (3) US7608578B2 (en)
EP (1) EP1307218B1 (en)
AT (1) ATE494003T1 (en)
AU (1) AU2001284774A1 (en)
CA (1) CA2417129A1 (en)
DE (1) DE60143801D1 (en)
WO (1) WO2002013854A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253274A1 (en) * 2003-06-11 2004-12-16 Allergan, Inc. Use of a clostridial toxin to reduce appetite
US20070003584A1 (en) * 2005-06-16 2007-01-04 Russell Anderson Liquid crystal polymer syringes and containers and methods of use for long term storage of filler materials

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7468060B2 (en) 1998-02-19 2008-12-23 Respiratory Diagnostic, Inc. Systems and methods for treating obesity and other gastrointestinal conditions
AU5275600A (en) 1999-05-18 2000-12-05 Silhouette Medical Inc. Surgical weight control device
US20050192629A1 (en) * 1999-06-25 2005-09-01 Usgi Medical Inc. Methods and apparatus for creating and regulating a gastric stoma
ES2435094T3 (en) * 2000-05-19 2013-12-18 C.R. Bard, Inc. Device and method of tissue capture and suturing
US7608578B2 (en) * 2000-08-11 2009-10-27 Temple University - Of The Commonwealth System Of Higher Education Obesity controlling method
US7737109B2 (en) * 2000-08-11 2010-06-15 Temple University Of The Commonwealth System Of Higher Education Obesity controlling method
US7033373B2 (en) 2000-11-03 2006-04-25 Satiety, Inc. Method and device for use in minimally invasive placement of space-occupying intragastric devices
US7077841B2 (en) 2001-03-26 2006-07-18 Curon Medical, Inc. Systems and methods employing a guidewire for positioning and stabilizing external instruments deployed within the body
US6558400B2 (en) * 2001-05-30 2003-05-06 Satiety, Inc. Obesity treatment tools and methods
US7083629B2 (en) * 2001-05-30 2006-08-01 Satiety, Inc. Overtube apparatus for insertion into a body
US6773440B2 (en) * 2002-07-02 2004-08-10 Satiety, Inc. Method and device for use in tissue approximation and fixation
US6746460B2 (en) * 2002-08-07 2004-06-08 Satiety, Inc. Intra-gastric fastening devices
US7214233B2 (en) * 2002-08-30 2007-05-08 Satiety, Inc. Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach
US7033384B2 (en) 2002-08-30 2006-04-25 Satiety, Inc. Stented anchoring of gastric space-occupying devices
US10383755B2 (en) 2002-09-09 2019-08-20 Brian Kelleher Device and method for endoluminal therapy
WO2004021894A1 (en) * 2002-09-09 2004-03-18 Brian Kelleher Device and method for endoluminal therapy
US7220237B2 (en) 2002-10-23 2007-05-22 Satiety, Inc. Method and device for use in endoscopic organ procedures
US7229428B2 (en) * 2002-10-23 2007-06-12 Satiety, Inc. Method and device for use in endoscopic organ procedures
US6656194B1 (en) * 2002-11-05 2003-12-02 Satiety, Inc. Magnetic anchoring devices
US7175638B2 (en) 2003-04-16 2007-02-13 Satiety, Inc. Method and devices for modifying the function of a body organ
MXPA05012303A (en) 2003-05-16 2006-02-22 Bard Inc C R Single intubation, multi-stitch endoscopic suturing system.
US7914543B2 (en) 2003-10-14 2011-03-29 Satiety, Inc. Single fold device for tissue fixation
US7097650B2 (en) * 2003-10-14 2006-08-29 Satiety, Inc. System for tissue approximation and fixation
US20050177176A1 (en) 2004-02-05 2005-08-11 Craig Gerbi Single-fold system for tissue approximation and fixation
US8828025B2 (en) * 2004-02-13 2014-09-09 Ethicon Endo-Surgery, Inc. Methods and devices for reducing hollow organ volume
MXPA06009971A (en) * 2004-02-27 2007-08-08 Satiety Inc Methods and devices for reducing hollow organ volume.
US8628547B2 (en) 2004-03-09 2014-01-14 Ethicon Endo-Surgery, Inc. Devices and methods for placement of partitions within a hollow body organ
US8449560B2 (en) 2004-03-09 2013-05-28 Satiety, Inc. Devices and methods for placement of partitions within a hollow body organ
US9028511B2 (en) 2004-03-09 2015-05-12 Ethicon Endo-Surgery, Inc. Devices and methods for placement of partitions within a hollow body organ
US8252009B2 (en) * 2004-03-09 2012-08-28 Ethicon Endo-Surgery, Inc. Devices and methods for placement of partitions within a hollow body organ
AU2005231323B2 (en) 2004-03-26 2011-03-31 Ethicon Endo-Surgery, Inc Systems and methods for treating obesity
US20060025808A1 (en) * 2004-06-22 2006-02-02 Thompson Ronald J Vagal nerve bulking arrangement
US20060036267A1 (en) * 2004-08-11 2006-02-16 Usgi Medical Inc. Methods and apparatus for performing malabsorptive bypass procedures within a patient's gastro-intestinal lumen
US7305993B2 (en) * 2004-10-26 2007-12-11 Medtronic, Inc. Implantation of tissue bulking devices
US7780592B2 (en) * 2004-10-29 2010-08-24 Medtronic, Inc. Distal portion of an endoscopic delivery system
US20060106288A1 (en) 2004-11-17 2006-05-18 Roth Alex T Remote tissue retraction device
US8088132B2 (en) * 2004-12-21 2012-01-03 Davol, Inc. (a C.R. Bard Company) Anastomotic outlet revision
US7771382B2 (en) * 2005-01-19 2010-08-10 Gi Dynamics, Inc. Resistive anti-obesity devices
US7736392B2 (en) 2005-04-28 2010-06-15 Medtronic, Inc. Bulking of upper esophageal sphincter for treatment of obesity
ATE529076T1 (en) * 2005-05-11 2011-11-15 Univ Texas DEVICE FOR TREATING OBESITY
US8726909B2 (en) * 2006-01-27 2014-05-20 Usgi Medical, Inc. Methods and apparatus for revision of obesity procedures
US7794386B2 (en) 2006-03-15 2010-09-14 Allergan, Inc. Methods for facilitating weight loss
US8187297B2 (en) 2006-04-19 2012-05-29 Vibsynt, Inc. Devices and methods for treatment of obesity
US20080092910A1 (en) * 2006-10-18 2008-04-24 Allergan, Inc. Apparatus and method for treating obesity using neurotoxins in conjunction with bariatric procedures
WO2008058323A1 (en) 2006-11-13 2008-05-22 The University Of Sydney Use of tropoelastin for repair or restoration of tissue
US8697155B2 (en) * 2008-07-22 2014-04-15 Mayo Foundation For Medical Education And Research Treatment of obesity and related disorders
US9278019B2 (en) 2009-04-03 2016-03-08 Metamodix, Inc Anchors and methods for intestinal bypass sleeves
US8702641B2 (en) 2009-04-03 2014-04-22 Metamodix, Inc. Gastrointestinal prostheses having partial bypass configurations
US9173760B2 (en) 2009-04-03 2015-11-03 Metamodix, Inc. Delivery devices and methods for gastrointestinal implants
BRPI1014701B8 (en) 2009-04-03 2021-06-22 Metamodix Inc modular system to treat metabolic disorders such as diabetes and obesity
AU2010271294B2 (en) 2009-07-10 2015-09-03 Metamodix, Inc. External anchoring configurations for modular gastrointestinal prostheses
AU2012207357B2 (en) 2011-01-19 2016-07-28 Fractyl Health, Inc. Devices and methods for the treatment of tissue
US9314362B2 (en) 2012-01-08 2016-04-19 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
US8382775B1 (en) 2012-01-08 2013-02-26 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
KR102086184B1 (en) 2012-02-27 2020-03-06 프랙틸 래브러토리스 인코포레이티드 Heat ablation systems,devices and methods for the treatment of tissue
KR102231179B1 (en) 2012-04-19 2021-03-22 프랙틸 래브러토리스 인코포레이티드 Tissue expansion devices, systems and methods
EP3714826A1 (en) 2012-07-30 2020-09-30 Fractyl Laboratories, Inc. Electrical energy ablation systems and devices for the treatment of tissue
EP2882362B1 (en) 2012-08-09 2024-01-03 Fractyl Health, Inc. Ablation systems, devices and methods for the treatment of tissue
WO2014055997A1 (en) 2012-10-05 2014-04-10 Fractyl Laboratories Inc. Methods, systems and devices for performing multiple treatments on a patient
EP2945566A4 (en) 2013-01-15 2016-10-26 Metamodix Inc System and method for affecting intestinal microbial flora
EP3003461B1 (en) 2013-06-04 2019-05-01 Fractyl Laboratories, Inc. Systems and devices for reducing the luminal surface area of the gastrointestinal tract
KR102284469B1 (en) * 2013-11-22 2021-08-02 프랙틸 헬쓰, 인코포레이티드 Systems, devices and methods for the creation of a therapeutic restriction in the gastrointestinal tract
US10959774B2 (en) 2014-03-24 2021-03-30 Fractyl Laboratories, Inc. Injectate delivery devices, systems and methods
US11185367B2 (en) 2014-07-16 2021-11-30 Fractyl Health, Inc. Methods and systems for treating diabetes and related diseases and disorders
US9844641B2 (en) 2014-07-16 2017-12-19 Fractyl Laboratories, Inc. Systems, devices and methods for performing medical procedures in the intestine
WO2016011269A1 (en) 2014-07-16 2016-01-21 Fractyl Laboratories, Inc. Methods and systems for treating diabetes and related diseases and disorders
US9956393B2 (en) 2015-02-24 2018-05-01 Elira, Inc. Systems for increasing a delay in the gastric emptying time for a patient using a transcutaneous electro-dermal patch
US10864367B2 (en) 2015-02-24 2020-12-15 Elira, Inc. Methods for using an electrical dermal patch in a manner that reduces adverse patient reactions
US10335302B2 (en) 2015-02-24 2019-07-02 Elira, Inc. Systems and methods for using transcutaneous electrical stimulation to enable dietary interventions
US10765863B2 (en) 2015-02-24 2020-09-08 Elira, Inc. Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy
US10376145B2 (en) 2015-02-24 2019-08-13 Elira, Inc. Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch
WO2016138176A1 (en) 2015-02-24 2016-09-01 Elira Therapeutics Llc Systems and methods for enabling appetite modulation and/or improving dietary compliance using an electro-dermal patch
US9622897B1 (en) 2016-03-03 2017-04-18 Metamodix, Inc. Pyloric anchors and methods for intestinal bypass sleeves
JP7044374B2 (en) 2016-05-19 2022-03-30 メタモディクス インコーポレイテッド Extraction device

Citations (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1174814A (en) * 1915-09-17 1916-03-07 Manville E J Machine Co Automatic threader.
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
US5322697A (en) * 1992-05-28 1994-06-21 Meyer James H Composition and method for inducing satiety
US5423872A (en) * 1992-05-29 1995-06-13 Cigaina; Valerio Process and device for treating obesity and syndromes related to motor disorders of the stomach of a patient
US5603950A (en) * 1990-08-14 1997-02-18 Ratjen; Werner Agent for oral intake
US5716222A (en) * 1995-11-03 1998-02-10 Advanced Interconnections Corporation Ball grid array including modified hard ball contacts and apparatus for attaching hard ball contacts to a ball grid array
US5868760A (en) * 1994-12-07 1999-02-09 Mcguckin, Jr.; James F. Method and apparatus for endolumenally resectioning tissue
US6044846A (en) * 1994-06-24 2000-04-04 Edwards; Stuart D. Method to treat esophageal sphincters
US6234955B1 (en) * 1998-12-11 2001-05-22 Enteric Medical Technologies, Inc. Method for vascular occulusive therapy in gastrointestinal system
US6251064B1 (en) * 1998-12-11 2001-06-26 Enteric Medical Technologies, Inc. Method for creating valve-like mechanism in natural body passageway
US20020022851A1 (en) * 2000-08-17 2002-02-21 Johns Hopkins University Gastric reduction endoscopy
US6358197B1 (en) * 1999-08-13 2002-03-19 Enteric Medical Technologies, Inc. Apparatus for forming implants in gastrointestinal tract and kit for use therewith
US20020055757A1 (en) * 2000-11-03 2002-05-09 Torre Roger De La Method and device for use in minimally invasive placement of intragastric devices
US20020055750A1 (en) * 1999-11-18 2002-05-09 Russell F. Durgin Apparatus and method for compressing body tissue
US20020065523A1 (en) * 2000-11-30 2002-05-30 Scimed Life Systems, Inc. Stapling and cutting in resectioning for full thickness resection devices
US6405732B1 (en) * 1994-06-24 2002-06-18 Curon Medical, Inc. Method to treat gastric reflux via the detection and ablation of gastro-esophageal nerves and receptors
US20020082621A1 (en) * 2000-09-22 2002-06-27 Schurr Marc O. Methods and devices for folding and securing tissue
US20020091395A1 (en) * 2001-01-08 2002-07-11 Shlomo Gabbay System to inhibit and/or control expansion of anatomical features
US20030055442A1 (en) * 1999-06-22 2003-03-20 Laufer Michael D. Method and devices for tissue reconfiguration
US6537314B2 (en) * 2000-01-31 2003-03-25 Ev3 Santa Rosa, Inc. Percutaneous mitral annuloplasty and cardiac reinforcement
US20030078466A1 (en) * 2001-08-31 2003-04-24 Silverman David E. Method for treating muscle in wall and apparatus for same
US6558400B2 (en) * 2001-05-30 2003-05-06 Satiety, Inc. Obesity treatment tools and methods
US6562034B2 (en) * 1998-02-19 2003-05-13 Curon Medical, Inc. Electrodes for creating lesions in tissue regions at or near a sphincter
US20030120321A1 (en) * 2001-11-09 2003-06-26 Pulsion Medical Systems Ag Implantable muscle stimulation device
US6589238B2 (en) * 1998-01-14 2003-07-08 Curon Medical, Inc. Sphincter treatment device
US6592596B1 (en) * 2000-05-10 2003-07-15 Scimed Life Systems, Inc. Devices and related methods for securing a tissue fold
US6591838B2 (en) * 1998-07-06 2003-07-15 Scimed Life Systems, Inc. Implant system and method for bulking tissue
US20030135206A1 (en) * 1998-02-27 2003-07-17 Curon Medical, Inc. Method for treating a sphincter
US20030144708A1 (en) * 2002-01-29 2003-07-31 Starkebaum Warren L. Methods and apparatus for retarding stomach emptying for treatment of eating disorders
US20040006351A1 (en) * 2002-07-02 2004-01-08 Jamy Gannoe Method and device for use in tissue approximation and fixation
US6675809B2 (en) * 2001-08-27 2004-01-13 Richard S. Stack Satiation devices and methods
US20040009224A1 (en) * 2000-08-11 2004-01-15 Miller Larry S Obesity controlling method
US20040015201A1 (en) * 2002-04-22 2004-01-22 Transneuronix, Inc. Process for electrostimulation treatment of obesity
US20040019388A1 (en) * 2002-07-24 2004-01-29 Starkebaum Warren L. Methods and implants for retarding stomach emptying to treat eating disorders
US20040030217A1 (en) * 2001-02-02 2004-02-12 Yeung Jeffrey E Urethral muscle controlled micro-invasive sphincteric closure device
US20040037865A1 (en) * 2000-08-11 2004-02-26 Miller Larry Sherwin Obesity controlling method
US20040044376A1 (en) * 2000-12-11 2004-03-04 Melina Flesler Acute and chronic electrical signal therapy for obesity
US6712814B2 (en) * 1998-02-19 2004-03-30 Curon Medical, Inc. Method for treating a sphincter
US20040082859A1 (en) * 2002-07-01 2004-04-29 Alan Schaer Method and apparatus employing ultrasound energy to treat body sphincters
US20040082963A1 (en) * 2002-10-23 2004-04-29 Jamy Gannoe Method and device for use in endoscopic organ procedures
US20040082950A1 (en) * 1994-06-24 2004-04-29 Curon Medical, Inc. Sphincter treatment apparatus
US20040087976A1 (en) * 2002-08-29 2004-05-06 Devries Robert B. Devices and methods for fastening tissue layers
US20040092892A1 (en) * 2002-11-01 2004-05-13 Jonathan Kagan Apparatus and methods for treatment of morbid obesity
US20040089313A1 (en) * 1998-02-19 2004-05-13 Curon Medical, Inc. Systems and methods for treating obesity and other gastrointestinal conditions
US6736828B1 (en) * 2000-09-29 2004-05-18 Scimed Life Systems, Inc. Method for performing endoluminal fundoplication and apparatus for use in the method
US20040096514A1 (en) * 1999-03-05 2004-05-20 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
US6740082B2 (en) * 1998-12-29 2004-05-25 John H. Shadduck Surgical instruments for treating gastro-esophageal reflux
US20040116949A1 (en) * 2002-12-11 2004-06-17 Ewers Richard C. Apparatus and methods for forming gastrointestinal tissue approximations
US20040122526A1 (en) * 2002-12-23 2004-06-24 Imran Mir A. Stomach prosthesis
US20040122470A1 (en) * 2002-07-02 2004-06-24 Deem Mark E. Methods and devices for luminal and sphincter augmentation
US6846312B2 (en) * 1998-01-14 2005-01-25 Curon Medical, Inc. GERD treatment apparatus and method
US20050024222A1 (en) * 2004-04-29 2005-02-03 Nelson Barry Michael Aircraft door detector/warning device sequence of operation
US20050033319A1 (en) * 2003-05-16 2005-02-10 Gambale Richard A. Single intubation, multi-stitch endoscopic suturing system
US20050033332A1 (en) * 2003-07-28 2005-02-10 Burnett Daniel R. Pyloric valve corking device and method
US20050033320A1 (en) * 2001-01-31 2005-02-10 Mcguckin James F. Apparatus and method for resectioning gastro-esophageal tissue
US20050033331A1 (en) * 2003-07-28 2005-02-10 Polymorfix, Inc., C/O Medventure Associates Pyloric valve obstructing devices and methods
US20050049718A1 (en) * 2002-11-01 2005-03-03 Valentx, Inc. Gastrointestinal sleeve device and methods for treatment of morbid obesity
US20050055039A1 (en) * 2003-07-28 2005-03-10 Polymorfix, Inc. Devices and methods for pyloric anchoring
US20050055038A1 (en) * 2002-09-09 2005-03-10 Brian Kelleher Device and method for endoluminal therapy
US20050075653A1 (en) * 1999-06-25 2005-04-07 Usgi Medical Inc. Apparatus and methods for forming and securing gastrointestinal tissue folds
US20050085923A1 (en) * 2002-12-02 2005-04-21 Gi Dynamics, Inc. Anti-obesity devices
US20050085829A1 (en) * 2002-05-17 2005-04-21 Esophyx, Inc. Transoral endoscopic gastroesophageal flap valve restoration device, assembly, system and method
US20050090873A1 (en) * 2003-10-22 2005-04-28 Imran Mir A. Gastrointestinal stimulation device
US20050090837A1 (en) * 2003-03-25 2005-04-28 Sixto Robert Jr. Endoscopic surgical instrument having a force limiting actuator
US6895258B1 (en) * 2000-08-14 2005-05-17 Kathrein-Werke Kg Space division multiple access strategy for data service
US6901295B2 (en) * 2001-07-14 2005-05-31 Virender K. Sharma Method and apparatus for electrical stimulation of the lower esophageal sphincter
US20050119671A1 (en) * 2003-11-13 2005-06-02 Usgi Medical Inc. Apparatus and methods for endoscopic suturing
US20050137643A1 (en) * 2003-11-28 2005-06-23 Mintchev Martin P. Gastrointestinal motility control
US20050143760A1 (en) * 2001-05-01 2005-06-30 Imran Mir A. Endoscopic gastric constriction device
US6986737B2 (en) * 2000-07-24 2006-01-17 Olympus Optical Co., Ltd. Endoscopic method for forming an artificial valve
US20060020278A1 (en) * 2003-07-28 2006-01-26 Polymorfix, Inc. Gastric retaining devices and methods
US6997931B2 (en) * 2001-02-02 2006-02-14 Lsi Solutions, Inc. System for endoscopic suturing
US7037315B2 (en) * 2001-09-14 2006-05-02 Dvl Aquisition Sub, Inc. Surgical suturing instrument and method of use
US20070032800A1 (en) * 2005-08-05 2007-02-08 Ortiz Mark S Apparatus for single pass gastric restriction
US20070032702A1 (en) * 2005-08-05 2007-02-08 Ortiz Mark S Method and apparatus for endoscopically performing gastric reduction surgery
US7175669B2 (en) * 2001-11-09 2007-02-13 Boston Scientific Corporation Intragastric stent for duodenum bypass
US7201757B2 (en) * 2003-06-20 2007-04-10 Enteromedics Inc. Gastro-esophageal reflux disease (GERD) treatment method and apparatus
US7220284B2 (en) * 2002-11-01 2007-05-22 Valentx, Inc. Gastrointestinal sleeve device and methods for treatment of morbid obesity
US20070129738A1 (en) * 2005-12-01 2007-06-07 Endogastric Solutions, Inc. Apparatus and method for concurrently forming a gastroesophageal valve and tightening the lower esophageal sphincter
US20070129735A1 (en) * 2005-07-13 2007-06-07 Filipi Charles J Systems and techniques for minimally invasive gastrointestinal procedures

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211765A (en) 1971-10-12 1980-07-08 Monsanto Company Method for controlling obesity
US3963780A (en) * 1971-12-22 1976-06-15 Sandoz, Inc. N,N'-disubstituted-p-phenylenediamines
US3968247A (en) 1974-02-25 1976-07-06 Sandoz, Inc. Substituted or unsubstituted p-alkanoyl toluenes as anti-diabetic agents
US3924003A (en) 1974-02-25 1975-12-02 Sandoz Ag Substituted or unsubstituted p-alkanoyl toluenes as anti-obesity and anti-diabetic agents
US3949073A (en) * 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
US4212876A (en) 1978-06-21 1980-07-15 Sandoz, Inc. Substituted or unsubstituted 2-phenylbenzimidazoles as anti-obesity agents
US4424208A (en) * 1982-01-11 1984-01-03 Collagen Corporation Collagen implant material and method for augmenting soft tissue
US4626539A (en) 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4592339A (en) * 1985-06-12 1986-06-03 Mentor Corporation Gastric banding device
US5223425A (en) * 1987-04-02 1993-06-29 The Beth Israel Hospital Association DNA encoding human adipsin with complement D activity
US5372807A (en) 1990-05-14 1994-12-13 University Of Medicine And Dentistry Of New Jersey Polymers containing antifibrotic agents, compositions containing such polymers, and methods of preparation and use
DE4025912A1 (en) * 1990-08-16 1992-02-20 Werner Ratjen ORAL INGREDIENTS
JPH04112759A (en) * 1990-08-30 1992-04-14 Terumo Corp Modifying agent for rice cooking, cooked rice, modified rice and preparation of cooked rice
US5234454A (en) 1991-08-05 1993-08-10 Akron City Hospital Percutaneous intragastric balloon catheter and method for controlling body weight therewith
JPH05255097A (en) * 1992-01-24 1993-10-05 Miyarisan Seibutsu Igaku Kenkyusho:Kk Liquid composition
US5480644A (en) * 1992-02-28 1996-01-02 Jsf Consultants Ltd. Use of injectable biomaterials for the repair and augmentation of the anal sphincters
US5355897A (en) 1992-04-16 1994-10-18 Ethicon, Inc. Method of performing a pyloroplasty/pylorectomy using a stapler having a shield
US5250053A (en) 1992-05-29 1993-10-05 Linvatec Corporation Suture shuttle device
US5312422A (en) 1992-07-16 1994-05-17 Linvatec Corporation Endoscopic suturing needle
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
EP2025353A2 (en) * 1993-04-30 2009-02-18 Massachusetts Institute of Technology Injectable polysaccharide-cell compositions
GB9405790D0 (en) 1994-03-23 1994-05-11 Univ London Sewing device
US5571116A (en) 1994-10-02 1996-11-05 United States Surgical Corporation Non-invasive treatment of gastroesophageal reflux disease
US5938668A (en) 1994-10-07 1999-08-17 United States Surgical Surgical suturing apparatus
US5752974A (en) * 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
US5912229A (en) * 1996-03-01 1999-06-15 Novo Nordisk Als Use of a pharmaceutical composition comprising an appetite-suppressing peptide
US5834027A (en) 1996-04-03 1998-11-10 Cardinale Fezler; Donna L. Injection of rhea and ostrich oils in animals
DE69736174T2 (en) 1996-04-19 2007-05-16 Applied Medical Resources Corp., Laguna Hills DEVICE FOR MOUNTING HOLDING CLIPS
US5792478A (en) 1996-07-08 1998-08-11 Advanced Uro Science Tissue injectable composition and method of use
US5820584A (en) 1997-08-28 1998-10-13 Crabb; Jerry A. Duodenal insert and method of use
US5877216A (en) * 1997-10-28 1999-03-02 Vivus, Incorporated Treatment of female sexual dysfunction
JP2002504390A (en) 1998-02-27 2002-02-12 キューロン メディカル,インコーポレイテッド Apparatus for electrosurgically treating esophageal sphincter
US6802841B2 (en) 1998-06-04 2004-10-12 Curon Medical, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
US6605294B2 (en) 1998-08-14 2003-08-12 Incept Llc Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
US6097984A (en) 1998-11-25 2000-08-01 Medtronic, Inc. System and method of stimulation for treating gastro-esophageal reflux disease
US6595910B2 (en) 1998-12-11 2003-07-22 Scimed Life Systems, Inc. Method for treating fecal incontinence
US6663639B1 (en) 1999-06-22 2003-12-16 Ndo Surgical, Inc. Methods and devices for tissue reconfiguration
US6494888B1 (en) 1999-06-22 2002-12-17 Ndo Surgical, Inc. Tissue reconfiguration
US6540789B1 (en) * 2000-06-15 2003-04-01 Scimed Life Systems, Inc. Method for treating morbid obesity
US6782339B2 (en) 2000-07-31 2004-08-24 Chart Industries, Inc. Differential pressure gauge for cryogenic fluids which selects a density value based on pressure measurement
US6916332B2 (en) 2001-05-23 2005-07-12 Scimed Life Systems, Inc. Endoluminal fundoplication device and related method for installing tissue fastener
US6845776B2 (en) 2001-08-27 2005-01-25 Richard S. Stack Satiation devices and methods
US7239912B2 (en) 2002-03-22 2007-07-03 Leptos Biomedical, Inc. Electric modulation of sympathetic nervous system
CA2486550C (en) 2002-06-12 2011-05-24 Scimed Life Systems, Inc. Suturing instruments
ES2291405T3 (en) 2002-09-04 2008-03-01 Endoart S.A. SURGICAL RING PROVIDED WITH A REMOTE CONTROL SYSTEM AND REVERSIBLE IN THE VARIATION OF YOUR DIAMETER.
US7175638B2 (en) * 2003-04-16 2007-02-13 Satiety, Inc. Method and devices for modifying the function of a body organ
EP1646332B1 (en) * 2003-07-18 2015-06-17 Edwards Lifesciences AG Remotely activated mitral annuloplasty system

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1174814A (en) * 1915-09-17 1916-03-07 Manville E J Machine Co Automatic threader.
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
US5603950A (en) * 1990-08-14 1997-02-18 Ratjen; Werner Agent for oral intake
US5322697A (en) * 1992-05-28 1994-06-21 Meyer James H Composition and method for inducing satiety
US5423872A (en) * 1992-05-29 1995-06-13 Cigaina; Valerio Process and device for treating obesity and syndromes related to motor disorders of the stomach of a patient
US6405732B1 (en) * 1994-06-24 2002-06-18 Curon Medical, Inc. Method to treat gastric reflux via the detection and ablation of gastro-esophageal nerves and receptors
US6044846A (en) * 1994-06-24 2000-04-04 Edwards; Stuart D. Method to treat esophageal sphincters
US20040082950A1 (en) * 1994-06-24 2004-04-29 Curon Medical, Inc. Sphincter treatment apparatus
US5868760A (en) * 1994-12-07 1999-02-09 Mcguckin, Jr.; James F. Method and apparatus for endolumenally resectioning tissue
US5716222A (en) * 1995-11-03 1998-02-10 Advanced Interconnections Corporation Ball grid array including modified hard ball contacts and apparatus for attaching hard ball contacts to a ball grid array
US6846312B2 (en) * 1998-01-14 2005-01-25 Curon Medical, Inc. GERD treatment apparatus and method
US6589238B2 (en) * 1998-01-14 2003-07-08 Curon Medical, Inc. Sphincter treatment device
US20040089313A1 (en) * 1998-02-19 2004-05-13 Curon Medical, Inc. Systems and methods for treating obesity and other gastrointestinal conditions
US6562034B2 (en) * 1998-02-19 2003-05-13 Curon Medical, Inc. Electrodes for creating lesions in tissue regions at or near a sphincter
US6712814B2 (en) * 1998-02-19 2004-03-30 Curon Medical, Inc. Method for treating a sphincter
US6866663B2 (en) * 1998-02-27 2005-03-15 Curon Medical, Inc. Method for treating a sphincter
US20030135206A1 (en) * 1998-02-27 2003-07-17 Curon Medical, Inc. Method for treating a sphincter
US6591838B2 (en) * 1998-07-06 2003-07-15 Scimed Life Systems, Inc. Implant system and method for bulking tissue
US6234955B1 (en) * 1998-12-11 2001-05-22 Enteric Medical Technologies, Inc. Method for vascular occulusive therapy in gastrointestinal system
US6248058B1 (en) * 1998-12-11 2001-06-19 Enteric Medical Technologies, Inc. Method for treating tracheo-esophageal fistulas
US6595909B2 (en) * 1998-12-11 2003-07-22 Scimed Life Systems, Inc. Method for treating tissue with an implant
US6530878B2 (en) * 1998-12-11 2003-03-11 Scimed Life Systems, Inc. Method for vascular occlusive therapy
US6533717B2 (en) * 1998-12-11 2003-03-18 Scimed Life Systems, Inc. Method for treating fecal incontinence
US6575896B2 (en) * 1998-12-11 2003-06-10 Scimed Life Systems, Inc. Method for treating tissue and apparatus for use therewith
US6251063B1 (en) * 1998-12-11 2001-06-26 Enteric Medical Technologies, Inc. Method for treating wall forming gastrointestinal tract
US6238335B1 (en) * 1998-12-11 2001-05-29 Enteric Medical Technologies, Inc. Method for treating gastroesophageal reflux disease and apparatus for use therewith
US6251064B1 (en) * 1998-12-11 2001-06-26 Enteric Medical Technologies, Inc. Method for creating valve-like mechanism in natural body passageway
US6740082B2 (en) * 1998-12-29 2004-05-25 John H. Shadduck Surgical instruments for treating gastro-esophageal reflux
US20040096514A1 (en) * 1999-03-05 2004-05-20 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
US20030055442A1 (en) * 1999-06-22 2003-03-20 Laufer Michael D. Method and devices for tissue reconfiguration
US20050075653A1 (en) * 1999-06-25 2005-04-07 Usgi Medical Inc. Apparatus and methods for forming and securing gastrointestinal tissue folds
US6695764B2 (en) * 1999-08-13 2004-02-24 Scimed Life Systems, Inc. Apparatus for treating wall of body cavity
US6358197B1 (en) * 1999-08-13 2002-03-19 Enteric Medical Technologies, Inc. Apparatus for forming implants in gastrointestinal tract and kit for use therewith
US20020055750A1 (en) * 1999-11-18 2002-05-09 Russell F. Durgin Apparatus and method for compressing body tissue
US6537314B2 (en) * 2000-01-31 2003-03-25 Ev3 Santa Rosa, Inc. Percutaneous mitral annuloplasty and cardiac reinforcement
US6592596B1 (en) * 2000-05-10 2003-07-15 Scimed Life Systems, Inc. Devices and related methods for securing a tissue fold
US6986737B2 (en) * 2000-07-24 2006-01-17 Olympus Optical Co., Ltd. Endoscopic method for forming an artificial valve
US20040037865A1 (en) * 2000-08-11 2004-02-26 Miller Larry Sherwin Obesity controlling method
US20040009224A1 (en) * 2000-08-11 2004-01-15 Miller Larry S Obesity controlling method
US6895258B1 (en) * 2000-08-14 2005-05-17 Kathrein-Werke Kg Space division multiple access strategy for data service
US20020022851A1 (en) * 2000-08-17 2002-02-21 Johns Hopkins University Gastric reduction endoscopy
US6572629B2 (en) * 2000-08-17 2003-06-03 Johns Hopkins University Gastric reduction endoscopy
US20020082621A1 (en) * 2000-09-22 2002-06-27 Schurr Marc O. Methods and devices for folding and securing tissue
US6736828B1 (en) * 2000-09-29 2004-05-18 Scimed Life Systems, Inc. Method for performing endoluminal fundoplication and apparatus for use in the method
US20020055757A1 (en) * 2000-11-03 2002-05-09 Torre Roger De La Method and device for use in minimally invasive placement of intragastric devices
US20020082616A1 (en) * 2000-11-30 2002-06-27 Mcalister Gary Stapling and cutting in resectioning for full thickness resection devices
US20020065523A1 (en) * 2000-11-30 2002-05-30 Scimed Life Systems, Inc. Stapling and cutting in resectioning for full thickness resection devices
US6398795B1 (en) * 2000-11-30 2002-06-04 Scimed Life Systems, Inc. Stapling and cutting in resectioning for full thickness resection devices
US20040044376A1 (en) * 2000-12-11 2004-03-04 Melina Flesler Acute and chronic electrical signal therapy for obesity
US6993391B2 (en) * 2000-12-11 2006-01-31 Metacure N.V. Acute and chronic electrical signal therapy for obesity
US20020091395A1 (en) * 2001-01-08 2002-07-11 Shlomo Gabbay System to inhibit and/or control expansion of anatomical features
US6572627B2 (en) * 2001-01-08 2003-06-03 Shlomo Gabbay System to inhibit and/or control expansion of anatomical features
US20050033320A1 (en) * 2001-01-31 2005-02-10 Mcguckin James F. Apparatus and method for resectioning gastro-esophageal tissue
US20040030217A1 (en) * 2001-02-02 2004-02-12 Yeung Jeffrey E Urethral muscle controlled micro-invasive sphincteric closure device
US6997931B2 (en) * 2001-02-02 2006-02-14 Lsi Solutions, Inc. System for endoscopic suturing
US20050143760A1 (en) * 2001-05-01 2005-06-30 Imran Mir A. Endoscopic gastric constriction device
US6558400B2 (en) * 2001-05-30 2003-05-06 Satiety, Inc. Obesity treatment tools and methods
US20030109892A1 (en) * 2001-05-30 2003-06-12 Deem Mark E. Obesity treatment tools and methods
US6901295B2 (en) * 2001-07-14 2005-05-31 Virender K. Sharma Method and apparatus for electrical stimulation of the lower esophageal sphincter
US6675809B2 (en) * 2001-08-27 2004-01-13 Richard S. Stack Satiation devices and methods
US20030078466A1 (en) * 2001-08-31 2003-04-24 Silverman David E. Method for treating muscle in wall and apparatus for same
US7037315B2 (en) * 2001-09-14 2006-05-02 Dvl Aquisition Sub, Inc. Surgical suturing instrument and method of use
US20030120321A1 (en) * 2001-11-09 2003-06-26 Pulsion Medical Systems Ag Implantable muscle stimulation device
US7175669B2 (en) * 2001-11-09 2007-02-13 Boston Scientific Corporation Intragastric stent for duodenum bypass
US20030144708A1 (en) * 2002-01-29 2003-07-31 Starkebaum Warren L. Methods and apparatus for retarding stomach emptying for treatment of eating disorders
US20040015201A1 (en) * 2002-04-22 2004-01-22 Transneuronix, Inc. Process for electrostimulation treatment of obesity
US20050085829A1 (en) * 2002-05-17 2005-04-21 Esophyx, Inc. Transoral endoscopic gastroesophageal flap valve restoration device, assembly, system and method
US20040082859A1 (en) * 2002-07-01 2004-04-29 Alan Schaer Method and apparatus employing ultrasound energy to treat body sphincters
US20040122470A1 (en) * 2002-07-02 2004-06-24 Deem Mark E. Methods and devices for luminal and sphincter augmentation
US20040006351A1 (en) * 2002-07-02 2004-01-08 Jamy Gannoe Method and device for use in tissue approximation and fixation
US20040019388A1 (en) * 2002-07-24 2004-01-29 Starkebaum Warren L. Methods and implants for retarding stomach emptying to treat eating disorders
US20040087976A1 (en) * 2002-08-29 2004-05-06 Devries Robert B. Devices and methods for fastening tissue layers
US20050055038A1 (en) * 2002-09-09 2005-03-10 Brian Kelleher Device and method for endoluminal therapy
US20040082963A1 (en) * 2002-10-23 2004-04-29 Jamy Gannoe Method and device for use in endoscopic organ procedures
US20050049718A1 (en) * 2002-11-01 2005-03-03 Valentx, Inc. Gastrointestinal sleeve device and methods for treatment of morbid obesity
US20050096750A1 (en) * 2002-11-01 2005-05-05 Jonathan Kagan Apparatus and methods for treatment of morbid obesity
US7220284B2 (en) * 2002-11-01 2007-05-22 Valentx, Inc. Gastrointestinal sleeve device and methods for treatment of morbid obesity
US20040092892A1 (en) * 2002-11-01 2004-05-13 Jonathan Kagan Apparatus and methods for treatment of morbid obesity
US20050085923A1 (en) * 2002-12-02 2005-04-21 Gi Dynamics, Inc. Anti-obesity devices
US20050065536A1 (en) * 2002-12-11 2005-03-24 Usgi Medical Inc. Apparatus and methods for forming gastrointestinal tissue approximations
US20040116949A1 (en) * 2002-12-11 2004-06-17 Ewers Richard C. Apparatus and methods for forming gastrointestinal tissue approximations
US7037343B2 (en) * 2002-12-23 2006-05-02 Python, Inc. Stomach prosthesis
US20040122526A1 (en) * 2002-12-23 2004-06-24 Imran Mir A. Stomach prosthesis
US20050090837A1 (en) * 2003-03-25 2005-04-28 Sixto Robert Jr. Endoscopic surgical instrument having a force limiting actuator
US20050033319A1 (en) * 2003-05-16 2005-02-10 Gambale Richard A. Single intubation, multi-stitch endoscopic suturing system
US7201757B2 (en) * 2003-06-20 2007-04-10 Enteromedics Inc. Gastro-esophageal reflux disease (GERD) treatment method and apparatus
US6994095B2 (en) * 2003-07-28 2006-02-07 Medventure Associates Iv Pyloric valve corking device and method
US20060020278A1 (en) * 2003-07-28 2006-01-26 Polymorfix, Inc. Gastric retaining devices and methods
US20050033332A1 (en) * 2003-07-28 2005-02-10 Burnett Daniel R. Pyloric valve corking device and method
US20050033331A1 (en) * 2003-07-28 2005-02-10 Polymorfix, Inc., C/O Medventure Associates Pyloric valve obstructing devices and methods
US20050055039A1 (en) * 2003-07-28 2005-03-10 Polymorfix, Inc. Devices and methods for pyloric anchoring
US20050090873A1 (en) * 2003-10-22 2005-04-28 Imran Mir A. Gastrointestinal stimulation device
US20050119671A1 (en) * 2003-11-13 2005-06-02 Usgi Medical Inc. Apparatus and methods for endoscopic suturing
US20050137643A1 (en) * 2003-11-28 2005-06-23 Mintchev Martin P. Gastrointestinal motility control
US20050024222A1 (en) * 2004-04-29 2005-02-03 Nelson Barry Michael Aircraft door detector/warning device sequence of operation
US20070129735A1 (en) * 2005-07-13 2007-06-07 Filipi Charles J Systems and techniques for minimally invasive gastrointestinal procedures
US20070032702A1 (en) * 2005-08-05 2007-02-08 Ortiz Mark S Method and apparatus for endoscopically performing gastric reduction surgery
US20070032800A1 (en) * 2005-08-05 2007-02-08 Ortiz Mark S Apparatus for single pass gastric restriction
US20070129738A1 (en) * 2005-12-01 2007-06-07 Endogastric Solutions, Inc. Apparatus and method for concurrently forming a gastroesophageal valve and tightening the lower esophageal sphincter

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253274A1 (en) * 2003-06-11 2004-12-16 Allergan, Inc. Use of a clostridial toxin to reduce appetite
US20070003584A1 (en) * 2005-06-16 2007-01-04 Russell Anderson Liquid crystal polymer syringes and containers and methods of use for long term storage of filler materials

Also Published As

Publication number Publication date
ATE494003T1 (en) 2011-01-15
US20100204673A1 (en) 2010-08-12
DE60143801D1 (en) 2011-02-17
EP1307218B1 (en) 2011-01-05
EP1307218A4 (en) 2004-03-17
AU2001284774A1 (en) 2002-02-25
EP1307218A1 (en) 2003-05-07
US20040009224A1 (en) 2004-01-15
CA2417129A1 (en) 2002-02-21
WO2002013854A1 (en) 2002-02-21
US7608578B2 (en) 2009-10-27

Similar Documents

Publication Publication Date Title
US7608578B2 (en) Obesity controlling method
US7737109B2 (en) Obesity controlling method
US6454785B2 (en) Percutaneous intragastric balloon catheter for the treatment of obesity
Vandenplas et al. Intragastric balloons in adolescents with morbid obesity
US7736392B2 (en) Bulking of upper esophageal sphincter for treatment of obesity
US7037344B2 (en) Apparatus and methods for treatment of morbid obesity
US20040019388A1 (en) Methods and implants for retarding stomach emptying to treat eating disorders
US20050246037A1 (en) Partial esophageal obstruction to limit food intake for treatment of obesity
US20050245957A1 (en) Biasing stretch receptors in stomach wall to treat obesity
US20090118749A1 (en) Pyloric Devices and Methods
Swidnicka-Siergiejko et al. Endoscopic treatment of obesity
WO2009126268A1 (en) Pyloric valve
Goyal et al. Endoscopic bariatric therapies
Miller Obesity: surgical options
RU2596873C1 (en) Method for reduction and correction of body weight using physical effect on human mind by creation the sense of fullness or absence of appetite state in it
RU2659020C2 (en) Method for treating obesity and reducing body weight using an intragastric stent instead of an intragastric balloon
Pyda et al. Initial experience with endoscopic sleeve gastroplasty in Poland
US20100160995A1 (en) Method for treating obesity
Roberts et al. Other Bariatric Procedures: Nerve Stimulation, Gastric Balloons, Intestinal Liners, and Others
Kadapa et al. WEIGHT REDUTION TREATMENTS BOON OR BANE FOR MANKIND A CRITICAL STATISTICAL ANALYSIS
WO2023102197A1 (en) Method of augmenting weight loss by pylorus-sparing gastric myotomy
WO2011063479A1 (en) Temporary esophageal non-surgical procedure for the treatment of obesity
Johner et al. Endoscopic bariatric procedures: assessment of postintervention safety and success
EP3597156B1 (en) Gastrointestinal implant and method for deploying the same
Favretti et al. The BioEnterics intragastric balloon for the nonsurgical treatment of obesity and morbid obesity

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION